Clinical Trial Update: 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update reports results for using 18F-fluciclovine PET/CT to stage muscle-invasive bladder cancer before radical cystectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Axumin (fluciclovine F-18)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Bladder Cancer, Urothelial Carcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-09